Oxygen uptake kinetics during low level exercise in patients with heart failure: Relation to neurohormones, peak oxygen consumption, and clinical findings

Heart

Volumn 81, Issue 2, 1999, Pages 121-127

  Brunner La Rocca, H P ^a,c   Weilenmann, D ^a   Follath, F ^a   Schlumpf, M ^a   Rickli, H ^a   Schalcher, C ^a   Maly, F E ^b   Candinas, R ^a   Kiowski, W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Heart failure; Low intensity exercise; Neurohormones; Oxygen consumption

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE; NORADRENALIN; OXYGEN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PERFORMANCE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; EXERCISE TEST; FEMALE; HUMAN; LUNG GAS EXCHANGE; MALE; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TREADMILL EXERCISE;

EID: 0033027337     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.2.121     Document Type: Article

References (40)

1. 1 Koike A, Hiroe M, Adachi H, et al. Oxygen uptake kinetics are determined by cardiac function at onset of exercise rather than peak exercise in patients with prior myocardial infarction. Circulation 1994;90:2324-32.
2. 2 Mancìni DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac ransplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
3. 3 Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFTVA Cooperative Studies Group. Circulation 1993;87:VI5-16.
4. 4 Stelken AM, Younis LT, Jennison SH, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996;27:345-52.
5. 5 Koike A, Yajima T, Adachi H, et al. Evaluation of exercise capacity using submaximal exercise at a constant work rate in patients with cardiovascular disease. Circulation 1995;91:1719-24.
6. 6 Sietsema KE, Ben Dov I, Zhang YY, et al. Dynamics of oxygen uptake for submaximal exercise and recovery in patients with chronic heart failure. Chest 1994;105:1693-700.
7. 7 Riley M, Porszasz J, Stanford CF, et al. Gas exchange responses to constant work rate exercise in chronic cardiac failure. Br Heart J 1994;72:150-5.
8. 8 Chelimsky Fallick C, Stevenson LW, Lem V, et al. Excessive oxygen deficit during low-level exercise in heart failure. Am J Cardiol 1995;76:799-802.
9. 9 Cross AMJ, Higginbotham MB. Oxygen deficit during exercise testing in heart failure. Relation to submaximal exercise tolerance. Chest 1995;107:904-8.
10. 10 Miller LW, Kubo SH, Young JB, et al. Report of the consensus conference on candidate selection for heart transplantation - 1993. J Heart Lung Transplant 1995;14:562-71.
11. 11 Miller LW. Candidate selection for heart transplantation. Cardiol Clin 1995;13:93-100.
12. 12 Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-7.
13. 13 Lewalter T, Rickli H, MacCarter D, et al. Oxygen uptake kinetics during low intensity exercise: relevance for rate adaptive pacemaker programming. Heart 1997;77:168-72.
14. 14 McIntyre KM, Vita JA, Lambrew CT, et al. A noninvasive method of predicting pulmonary-capillary wedge pressure. N Engl J Med 1992;327:1715-20.
15. 15 American College of Sports Medicine. Guidelines for grades exercise testing and prescription. Philadelphia: Lea and Febiger, 1986:157-72.
16. 16 Whipp BJ. Rate constant for the kinetics of oxygen uptake during light exercise. J Appl Physiol 1971;30:261-3.
17. 17 Bauch HJ, Kelsch U, Hauss WH. Einfache, schnelle, selektive und quantitative Bestimmung von adrenalin und Noradrenalin im Plasma durch Kombination von Flüssigextraktion, HPLC-Trennung und elektrochemischer Detektion. J Clin Chem Clin Biochem 1986;24:651-8.
18. 18 Brunner-La Rocca HP, Fatio R, Follath F. Non-invasive assessment of pulmonary-capillary wedge pressure in patients with congestive heart failure [abstract]. Eur Heart J 1997;18:646.
19. 19 Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. Philadelphia: Lea and Febiger, 1994.
20. 20 Weiler-Ravell D, Cooper DM, Whipp BJ, et al. The control of breathing at the start of exercise as influenced by posture. J Appl Physiol 1983;55:1460-6.
21. 21 Springer C, Barstow TJ, Wasserman K, et al. Oxygen uptake and heart rate responses during hypoxic exercise in children and adults. Med Sci Sports Exerc 1991;23:71-9.
22. 22 Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988;77:552-9.
23. 23 Lipkin DP, Scriven AJ, Crake T, et al. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ 1986;292:653-5.
24. 24 Faggiano P, D'Aloia A, Gualeni A, et al. Assessment of oxygen uptake during the 6-minute walking test in patients with heart failure: preliminary experience with a portable device. Am Heart J 1997;134:203-6.
25. 25 Cahalin LP, Mathier MA, Semigran MJ, et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996;110:325-32.
26. 26 Riley M, McParland J, Stanford CF, et al. Oxygen consumption during corridor walk testing in chronic cardiac failure. Eur Heart J 1992;13:789-93.
27. 27 Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 1993;270:1702-7.
28. 28 Australia-New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995;92:212-18.
29. 29 Levine TB. The design of the mortality assessment in congestive heart failure trial (MACH-1, mibefradil). Clin Cardiol 1997;20:320-6.
30. 30 Swedberg K, Gundersen T. The role of exercise testing in heart failure. J Cardiovasc Pharmacol 1993;22(suppl 9):S13-17.
31. 31 Loeppky JA, Greene ER, Hoekenga DE, et al. Beat-by-beat stroke volume assessment by pulsed Doppler in upright and supine exercise. J Appl Physiol 1981;50:1173-82.
32. 32 Rowell LB. Human circulation during physical stress. New York: Oxford University Press, 1986:215.
33. 2 uptake and heart rate as affected by exercise work rate. J Appl Physiol 1989;67:2535-41.
34. 34 Janicki JS, Gupta S, Ferris ST, et al. Long-term reproducibility of respiratory gas exchange measurements during exercise in patients with stable cardiac failure. Chest 1990;97:12-17.
35. 35 Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990;65:903-8.
36. 36 Kaye DM, Lefkovits J, Jennings GL, et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995,26:1257-63.
37. 37 Benedict CR, Shelton B, Johnstone DE, et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 1996;94:690-7.
38. 38 Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-9.
39. 39 Swedberg K, Eneroth P, Kjekshus J, The CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with chronic congestive heart failure and their relation to mortality. Circulation 1990,82:1730-6.
40. 40 Petersen ES, Whipp BJ, Davis JA, et al. Effects of β-adrenergic blockade on ventilation and gas exchange during exercise in humans. J Appl Physiol 1983;54:1306-13.